Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Pancreatic Cancer Discovery Advances Toward First-of-Its-Kind Clinical Trial

Sylvester researchers identified IL1RAP as a key driver of pancreatic cancer treatment resistance. Backed by a V Foundation grant, the findings are advancing into a first-of-its-kind clinical trial combining IL1RAP-targeted therapy with chemoimmunotherapy before surgery.

June 23, 2026


July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026